Browsing "1. Journal Papers" by Author : 4229

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 70 to 129 of 432

This table browses all dspace content
Issue DateTitleJournal Title
2019Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients Cancer Research and Treatment
2009Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction YONSEI MEDICAL JOURNAL
2007Bilateral Breast Cancer: Differential Diagnosis Using Histological and Biological Parameters JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2021Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in AsiaTARGETED ONCOLOGY
2002Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment.INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
2011Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial.BREAST CANCER
2012Body image, sexual function and depression in Korean patients with breast cancer: modification by 5-HTT polymorphismSUPPORTIVE CARE IN CANCER
2023Breakthroughs in the Systemic Treatment of HER2-Positive Advanced/Metastatic Gastric Cancer: From Singlet Chemotherapy to Triple CombinationJOURNAL OF GASTRIC CANCER
2013Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trialLANCET ONCOLOGY
2008Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2017Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer ONCOTARGET
2018Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric CancerANTICANCER RESEARCH
2011CD44-SLC1A2 gene fusions in gastric cancer. SCIENCE TRANSLATIONAL MEDICINE
2003cDNA Microarray Experiment: Design Issues in Early Stage and the Need of Normalization CANCER RESEARCH AND TREATMENT
2007Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapyACTA ONCOLOGICA
2020Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot studySUPPORTIVE CARE IN CANCER
2017Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer ONCOLOGY LETTERS
2002Changes of telomerase activity and proliferation by inhibition of reverse transcriptase activity in human cancer cell. CANCER RESEARCH AND TREATMENT
2009Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients.ONCOLOGY RESEARCH
1999Changes of telomerase and telomere lengths in paired normal and cancer tissues of breastInternational Journal of Oncology
2007Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean instituteANNALS OF SURGICAL ONCOLOGY
2013Changing treatment patterns in elderly patients with resectable colon cancerASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
1994Changing trends in histologic types of lung cancer during the last decade(1981-1990) in Korean Hospital-based studyLUNG CANCER
2010Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progressionCANCER SCIENCE
2008Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients BMC CANCER
2020Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer MOLECULAR THERAPY-ONCOLYTICS
2010Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patientsCANCER LETTERS
2016Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer. CANCER RESEARCH AND TREATMENT
2013Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agentINVESTIGATIONAL NEW DRUGS
2011Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2010Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites CANCER RESEARCH AND TREATMENT
2015Clinicopathological features and prognostic significance of HER2 expression in gastric cancerONCOLOGY
2013Combination of CYP inhibitor with MEK/ERK inhibitor enhances the inhibitory effect on ERK in BRAF mutant colon cancer cells.ANTICANCER RESEARCH
2014Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trialINVESTIGATIONAL NEW DRUGS
1999Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcomaONCOLOGY REPORTS
2021Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysisEUROPEAN JOURNAL OF CANCER
1997Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfateCANCER LETTERS
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer ONCOTARGET
2016Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy ONCOTARGET
2019Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer Journal for Immunotherapy of Cancer
2004Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acidsJOURNAL OF INORGANIC BIOCHEMISTRY
2009Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancerINTERNATIONAL JOURNAL OF ONCOLOGY
1997Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinomaCANCER
2000Correlation of tissue and blood plasminogen activation system in breast cancerJournal of Neurology, Neurosurgery and Psychiatry
2009Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC).BREAST CANCER RESEARCH AND TREATMENT
2016Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After GastrectomyANNALS OF SURGERY
2005Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere lossBREAST CANCER RESEARCH AND TREATMENT
2008Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancerARCHIVES OF SURGERY
2017Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab ONCOTARGET
2021Detection of asymptomatic recurrence improves survival of gastric cancer patients CANCER MEDICINE
2005Determination of genes related to gastrointestinal tract origin cancer cells using a cDNA microarray CLINICAL CANCER RESEARCH
2021Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population GUT
2019Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaOncology
2007Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancerBREAST CANCER RESEARCH AND TREATMENT
1998Different expression patterns of MMP-2 and MMP-9 in breast cancerONCOLOGY REPORTS
2005Different role of functional domains of hTR in DNA binding to telomere and telomerase reconstruction FEBS LETTERS
2017Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia ANNALS OF SURGERY
2024Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinomaBIOORGANIC CHEMISTRY
2008Disease Prediction Using Ranks of Gene Expressions Genomics & Informatics
2011DNA methylation predicts recurrence from resected stage III proximal colon cancer CANCER

Browse

Links